News

Filter

Current filters:

Presidio Pharmaceuticals

Boehringer Ingelheim links with Presidio on interferon-free hepatitis C treatment regimens

10-09-2013

The US subsidiary of German family-owned drug major Boehringer Ingelheim says it has completed patient…

Anti-viralsBoehringer IngelheimdeleobuvirfaldaprevirPharmaceuticalPPI-668Presidio PharmaceuticalsResearch

Presidio Pharma inks deal with Boehringer Ingelheim for hep C combo

14-03-2013

Privately-held USA-based Presidio Pharmaceuticals has entered into a non-exclusive collaboration with…

Anti-viralsBI207127Boehringer IngelheimfaldaprevirPharmaceuticalPPI-668Presidio PharmaceuticalsResearch

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva

03-12-2012

Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

BioCryst and Presidio to merge, creating new competitor in HCV arena

22-10-2012

USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top